Skip to main content
SpringerLink
Log in

Vanadium and diabetes. What about vanadium toxicity?: A reply

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Poucheret P, Verma S, Grynpas MD, McNeill JH: Vanadium and diabetes. Mol Cell Biochem 188: 73–80, 1998

    Google Scholar 

  2. Dai S, McNeill JH: One-year treatment of nondiabetic and STZ-diabetic rats with vanadyl sulphate did not alter blood pressure or haematological indices. Pharmacol Toxicol 74: 110–115, 1994

    Google Scholar 

  3. Dai S, Thompson KH, McNeill JH: One-year treatment of STZ-induced diabetic rats with vanadyl sulphate. Pharmacol Toxicol 74: 101–109, 1994

    Google Scholar 

  4. Dai S, Thompson KH, Vera E, McNeill JH: Toxicity studies on one-year treatment of non-diabetic and STZ-diabetic rats with vanadyl sulphate. Pharmacol Toxicol 75: 265–273, 1994

    Google Scholar 

  5. Dai S, Yuen VG, Orvig C, McNeill JH: Prevention of diabetesinduced pathology in STZ-diabetic rats by bis(maltolato)-oxovanadium (IV). Pharmacol Commun 3: 311–321, 1993

    Google Scholar 

  6. Mongold JJ, Cros GH, Vian L, Tep A, Ramanadham S, Siou G, Diaz J, McNeill JH, Serrano JJ: Toxicological aspects of vanadyl sulfate on diabetic rats: Effects on vanadium levels and pancreatic β-cell morphology. Pharmacol and Toxicol 67: 192–198, 1990

    Google Scholar 

  7. Yuen VG, Orvig C, Thompson KH, McNeill JH: Improvement in cardiac dysfunction in STZ-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium (IV). Can J Physiol Pharmacol 71: 270–276, 1993

    Google Scholar 

  8. Thompson KH, Battell M, McNeill JH: Toxicology of vanadium in mammals. In: J.O. Nriagu (ed). Vanadium in the Environment. Part 2: Health Effects. John Wiley amp; Sons Inc, 1998, pp 21–37

  9. Srivastava AK: Potential use of vanadium compounds in the treatment of diabetes mellitus. Exp Opin Invest Drugs 4: 525–536, 1995

    Google Scholar 

  10. Cruz TF, Morgan A, Min W: In vitro and in vivo antineoplastic effects of ortrovanadate. Mol Cell Biochem 153: 161–166, 1995

    Google Scholar 

  11. Fantus IG, Tsiana E: Multifunctional actions of vanadium compounds on insulin signaling pathways: Evidence for preferential enhancement of metabolic vs. mitogenic effects. Mol Cell Biochem 182: 109–119, 1998

    Google Scholar 

  12. Ganguli S, Reuland SP, Franklin LA, Deakins DD, Johnston WJ, Pasha A: Effects of maternal vanadate treatment on fetal development. Life Sci 55: 1267–1276, 1994a

    Google Scholar 

  13. Ganguli S, Reuland SP, Franklin LA, Tucker M: Effect of vanadate on reproductive efficiency in normal and streptozocin-treated diabetic rats. Metabolism 43: 1384–1388, 1994b

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, V6T 1Z3, Canada

    John H. McNeill

Authors
  1. John H. McNeill
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McNeill, J.H. Vanadium and diabetes. What about vanadium toxicity?: A reply. Mol Cell Biochem 208, 167–168 (2000). https://doi.org/10.1023/A:1007019129085

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007019129085

Keywords

Search

Navigation